GetTopicDetailResponse(id=81916156988, topicName=來那替尼, introduction=來那替尼, content=null, image=null, comments=0, allHits=581, url=https://h5.medsci.cn/topic?id=61569, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=33755, tagList=[TagDto(tagId=33755, tagName=來那替尼)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2219557, encodeId=fc0f221955ee1, content=<a href='/topic/show?id=81916156988' target=_blank style='color:#2F92EE;'>#來那替尼#</a> <a href='/topic/show?id=0b8a10814488' target=_blank style='color:#2F92EE;'>#HER2陽性腦轉移乳腺癌#</a> <a href='/topic/show?id=d94e11e7522b' target=_blank style='color:#2F92EE;'>#恩美曲妥珠單抗#</a>, objectTitle=Ann. Oncol | 來那替尼和恩美曲妥珠單抗聯(lián)合治療HER2陽性腦轉移乳腺癌：一項前瞻性臨床試驗的結果, objectType=article, longId=838532, objectId=5448838532db, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240719/1721352199808_92910.jpg, objectUrl=/article/show_article.do?id=5448838532db, replyNumber=0, likeNumber=53, createdTime=2024-08-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5448838532db, moduleTitle=Ann. Oncol | 來那替尼和恩美曲妥珠單抗聯(lián)合治療HER2陽性腦轉移乳腺癌：一項前瞻性臨床試驗的結果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5448838532db)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
